The U.S. Department of Commerce has launched a national security investigation into imports of personal protective equipment, medical consumables and medical equipment, signaling a potential for future tariffs.
The probe, initiated under Section 232 of the Trade Expansion Act of 1962, comes amid other recent tariff actions by the Trump administration.
Here are four notes:
- The investigation will assess whether U.S. reliance on foreign medical imports poses a risk to national security, according to a Sept. 24 letter from the Bureau of Industry and Security. Covered products include surgical masks, gloves, ventilators, imaging machines and other critical medical tools. The review excludes pharmaceuticals, which are subject to a separate Section 232 investigation.
- The department is soliciting comments, data and analysis from stakeholders to evaluate risks related to supply chain concentration, foreign subsidies, unfair trade practices and the feasibility of increasing domestic production.
- This comes after earlier this month, President Donald Trump signed an executive order exempting pharmaceuticals under active Section 232 review from additional tariffs. The move, however, is contingent on trading partners reaching broader trade agreements with the U.S.
- The probe is part of a broader push by the Trump administration to reduce dependence on foreign suppliers. Recent tariff actions include a 20% duty on Chinese imports, 25% on imports from Mexico and 35% on Canada, with additional levies on steel, aluminum, autos and copper.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.